ADMA
ADMA Biologics Inc
9.40$
-1.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 63.4% | 57.9% | 52.2% | 46.4% | 50.2% | 46.1% | 46.8% | 44.9% | 43.7% | 36.2% | 29.5% | 30.6% | 35.3% | |
| 36.6% | 42.1% | 47.8% | 53.6% | 49.8% | 53.9% | 53.2% | 55.1% | 56.3% | 63.8% | 70.5% | 69.4% | 64.7% | |
| 0.9% | 0.6% | 0.5% | 0.5% | 0.3% | 0.3% | 0.7% | 0.8% | 1.1% | 1.0% | 2.3% | 4.8% | 2.2% | |
| 21.9% | 21.0% | 19.1% | 15.5% | 15.5% | 19.8% | 21.0% | 18.2% | 16.2% | 16.9% | 23.4% | 21.5% | 19.3% | |
| 23.7% | 22.8% | 21.1% | 17.0% | 16.7% | 21.3% | 22.8% | 20.0% | 18.3% | 18.7% | 26.6% | 27.2% | 22.4% | |
| 12.9% | 19.3% | 26.7% | 36.6% | 33.1% | 32.6% | 30.4% | 35.1% | 38.0% | 45.1% | 43.9% | 42.2% | 42.3% | |
| 9.5% | 8.4% | 4.6% | 3.5% | 2.9% | 2.4% | 1.7% | 1.5% | 1.2% | 1.2% | 1.8% | 2.8% | 1.7% | |
| 3.8% | -23.9% | 22.5% | 33.4% | 30.7% | 29.5% | 29.1% | 32.9% | 35.4% | 44.3% | 49.9% | 40.4% | 42.3% | |
| 9.3% | 0.0% | 0.7% | 3.5% | 0.7% | -65.7% | 5.7% | 4.8% | 8.3% | 8.8% | 10.3% | 10.0% | 9.3% | |
| 3.8% | -23.9% | 21.7% | 29.9% | 30.0% | 95.2% | 23.4% | 28.1% | 27.1% | 35.5% | 39.6% | 30.4% | 33.0% | |
| 16.4% | -12.6% | 29.7% | 38.9% | 35.2% | 33.6% | 32.6% | 36.1% | 38.2% | 46.9% | 53.3% | 46.0% | 45.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.